Managers / Q4 2019
Broadfin Capital, LLC
CIK 0001511901 · 300 PARK AVENUE, 25TH FLOOR, NEW YORK, NY, 10022 · 212-808-2460
Reported Value
$747M
Q4 2019
Positions
40
Filings on Record
5
2019–present window
Filed
Feb 14, 2020
original filing
Summary
Broadfin Capital, Llc reported $747M in U.S.-listed holdings across 40 positions for Q4 2019.
Its largest position, Biodelivery Sciences Intl In, represents 3.6% of the portfolio.
Compared with Q3 2019, the fund opened 11 new positions and exited 15.
Reported Value by Quarter
13F Reported Value
Portfolio Composition
By security type
- ETP · 41.2% · $307M
- Common Stock · 37.3% · $278M
- Other · 21.6% · $161M
Quarter-over-Quarter Changes full breakdown →
Holdings — Q4 2019
Filing History
Other Included Managers
This filing reports holdings on behalf of 1 additional manager.
- Broadfin Healthcare Master Fund Ltd28-14254
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.